Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Two-State Receptor Model

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...

Non-gated Ion Channels

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

G Protein-coupled Receptors

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enhancing the Predictive Power of Macrocyclic Drug Permeability by Knowledge Distillation from Analogous Pretraining Data.

Journal of medicinal chemistry·2025

Same author

Pathological gain-of-function human variants in the GRIK2 kainate receptor gene cause wide-ranging behavioral dysfunction and seizures in mouse models.

Neurobiology of disease·2025

Same author

Designing fluorescent estrogen mimetic 7-hydroxycoumarin probe substrates for human sulfotransferase enzymes.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025

Same author

Bridging the gap: insights into sensorimotor deficits in NMDA receptor antibody encephalitis.

The Journal of clinical investigation·2025

Same author

Atomistic simulations reveal impacts of missense mutations on the structure and function of SynGAP1.

Briefings in bioinformatics·2024

Same author

Building shape-focused pharmacophore models for effective docking screening.

Journal of cheminformatics·2024

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Exploring kainate receptor pharmacology using molecular dynamics simulations.

Pekka A Postila¹, Geoffrey T Swanson, Olli T Pentikäinen

¹Department of Biological and Environmental Science & Nanoscience Center, FI-40014 University of Jyväskylä, Survontie 9/Ambiotica, Finland.

Neuropharmacology

|September 10, 2009

Summary

Computational methods can now predict how drug molecules interact with ionotropic glutamate receptors (iGluRs). Molecular dynamics simulations accurately classify ligand function, accelerating pharmaceutical research for iGluR targets.

Related Experiment Videos

Last Updated: Jun 20, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Area of Science:

Neuroscience
Computational Chemistry
Pharmacology

Background:

Ionotropic glutamate receptors (iGluRs) are crucial drug targets.
Developing selective iGluR ligands is experimentally challenging and time-consuming.

Purpose of the Study:

To introduce a computational method for evaluating ligand-iGluR pharmacology.
To predict ligand function (agonist, partial agonist, antagonist) using molecular dynamics simulations.

Main Methods:

Ligands were docked into the closed ligand-binding domain of GluK1 kainate receptors.
Molecular dynamics (MD) simulations were used to observe ligand-induced changes in the receptor's bi-lobed interface.
The computational model was validated against experimental binding and electrophysiology data.

Main Results:

MD simulations accurately predicted whether ligands caused domain closure (agonists) or opening (partial agonists/antagonists).
Detailed binding modes and structure-activity relationships were elucidated.
The study demonstrated ligand-induced opening of the GluK1 ligand-binding domain.

Conclusions:

Molecular dynamics simulations offer a reproducible and predictive approach to iGluR pharmacology.
This computational strategy can accelerate the discovery and classification of iGluR-targeting drugs.